Suchergebnisse - "Myeni, Sebenzile K"

PubPharm (30)

1

Immunogenicity and protective efficacy of one- and two-dose regimens of the Ad26.COV2.S COVID-19 vaccine candidate in adult and aged rhesus macaques

enthalten in: bioRxiv.org | 2024

von Solforosi, L. | Kuipers, H. | Huber, S. | +34

2

Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine : safety and immunogenicity of a fractional booster dose

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Roozen, G. | Prins, M. | Prins, C. | +18

3

Impact of SARS-CoV-2 spike stability and RBD exposure on antigenicity and immunogenicity

enthalten in: Scientific reports | 2024

von Rutten, L. | Swart, M. | Koornneef, A. | +19

4

Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo

enthalten in: PLoS pathogens | 2024

von van Huizen, M. | Bloeme-Ter Horst, J. | de Gruyter, H. | +11

5

The Main Protease of Middle East Respiratory Syndrome Coronavirus Induces Cleavage of Mitochondrial Antiviral Signaling Protein to Antagonize the Innate Immune Response

enthalten in: Viruses | 2024

von van Huizen, M. | Vendrell, X. | de Gruyter, H. | +5

6

Multiantigen pan-sarbecovirus DNA vaccines generate protective T cell immune responses

enthalten in: JCI insight | 2023

von van Bergen, J. | Camps, M. | Pardieck, I. | +8

7

Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant

enthalten in: Hepatology communications | 2023

von Mehta, G. | Riva, A. | Ballester, M. | +93

8

Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase

enthalten in: Nature communications | 2023

von Myeni, S. | Bredenbeek, P. | Knaap, R. | +11

9

Ad26.COV2.S-elicited immunity protects against G614 spike variant SARS-CoV-2 infection in Syrian hamsters and does not enhance respiratory disease in challenged animals with breakthrough infection after sub-optimal vaccine dosing

enthalten in: bioRxiv.org | 2022

von van der Lubbe, J. | Rosendahl Huber, S. | Vijayan, A. | +24

10

Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients : Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance

enthalten in: Cells | 2022

von Zlei, M. | Sidorov, I. | Joosten, S. | +25